Overview

Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Islet Amyloid Polypeptide
Pramlintide